<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33684213</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>12</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1362-4962</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>06</Day></PubDate></JournalIssue><Title>Nucleic acids research</Title><ISOAbbreviation>Nucleic Acids Res</ISOAbbreviation></Journal><ArticleTitle>Reactive astrocytes in ALS display diminished intron retention.</ArticleTitle><Pagination><StartPage>3168</StartPage><EndPage>3184</EndPage><MedlinePgn>3168-3184</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/nar/gkab115</ELocationID><Abstract><AbstractText>Reactive astrocytes are implicated in amyotrophic lateral sclerosis (ALS), although the mechanisms controlling reactive transformation are unknown. We show that decreased intron retention (IR) is common to human-induced pluripotent stem cell (hiPSC)-derived astrocytes carrying ALS-causing mutations in VCP, SOD1 and C9orf72. Notably, transcripts with decreased IR and increased expression are overrepresented in reactivity processes including cell adhesion, stress response and immune activation. This was recapitulated in public-datasets for (i) hiPSC-derived astrocytes stimulated with cytokines to undergo reactive transformation and (ii) in vivo astrocytes following selective deletion of TDP-43. We also re-examined public translatome sequencing (TRAP-seq) of astrocytes from a SOD1 mouse model, which revealed that transcripts upregulated in translation significantly overlap with transcripts exhibiting decreased IR. Using nucleocytoplasmic fractionation of VCP mutant astrocytes coupled with mRNA sequencing and proteomics, we identify that decreased IR in nuclear transcripts is associated with enhanced nonsense mediated decay and increased cytoplasmic expression of transcripts and proteins regulating reactive transformation. These findings are consistent with a molecular model for reactive transformation in astrocytes whereby poised nuclear reactivity-related IR transcripts are spliced, undergo nuclear-to-cytoplasmic translocation and translation. Our study therefore provides new insights into the molecular regulation of reactive transformation in astrocytes.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ziff</LastName><ForeName>Oliver J</ForeName><Initials>OJ</Initials><AffiliationInfo><Affiliation>The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Hospital for Neurology and Neurosurgery, University College London NHS Foundation Trust, London, WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taha</LastName><ForeName>Doaa M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Zoology, Faculty of Science, Alexandria University, Alexandria 21511, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crerar</LastName><ForeName>Hamish</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clarke</LastName><ForeName>Benjamin E</ForeName><Initials>BE</Initials><AffiliationInfo><Affiliation>The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chakrabarti</LastName><ForeName>Anob M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UCL Genetics Institute, University College London, Gower Street, London WC1E 6BT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelly</LastName><ForeName>Gavin</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neeves</LastName><ForeName>Jacob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tyzack</LastName><ForeName>Giulia E</ForeName><Initials>GE</Initials><AffiliationInfo><Affiliation>The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luscombe</LastName><ForeName>Nicholas M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UCL Genetics Institute, University College London, Gower Street, London WC1E 6BT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Okinawa Institute of Science &amp; Technology Graduate University, Okinawa 904-0495, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patani</LastName><ForeName>Rickie</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Hospital for Neurology and Neurosurgery, University College London NHS Foundation Trust, London, WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>FC010110</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/L016311/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>FC010110</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>103760/Z/14/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>FC010110</GrantID><Acronym>CRUK_</Acronym><Agency>Cancer Research UK</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/S006591/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nucleic Acids Res</MedlineTA><NlmUniqueID>0411011</NlmUniqueID><ISSNLinking>0305-1048</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000655624">CACFD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015220">Calcium Channels</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C578077">TDP-43 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.6</RegistryNumber><NameOfSubstance UI="C000614178">VCP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.6</RegistryNumber><NameOfSubstance UI="D000074405">Valosin Containing Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017398" MajorTopicYN="Y">Alternative Splicing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015220" MajorTopicYN="N">Calcium Channels</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002467" MajorTopicYN="N">Cell Nucleus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003593" MajorTopicYN="N">Cytoplasm</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007438" MajorTopicYN="Y">Introns</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014178" MajorTopicYN="N">Translocation, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000074405" MajorTopicYN="N">Valosin Containing Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>8</Day><Hour>17</Hour><Minute>10</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33684213</ArticleId><ArticleId IdType="pmc">PMC8034657</ArticleId><ArticleId IdType="doi">10.1093/nar/gkab115</ArticleId><ArticleId IdType="pii">6155937</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M.et al. .. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006; 314:130&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan M.C., Vucic S., Talbot K., McDermott C.J., Hardiman O., Shefner J.M., Al-Chalabi A., Huynh W., Cudkowicz M., Talman P.et al. .. Improving clinical trial outcomes in amyotrophic lateral sclerosis. Nat. Rev. Neurol. 2020; 17:104&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7747476</ArticleId><ArticleId IdType="pubmed">33340024</ArticleId></ArticleIdList></Reference><Reference><Citation>Shatunov A., Al-Chalabi A.. The genetic architecture of ALS. Neurobiol. Dis. 2020; 147:105156.</Citation><ArticleIdList><ArticleId IdType="pubmed">33130222</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson J.O., Mandrioli J., Benatar M., Abramzon Y., Van&#xa0;Deerlin V.M., Trojanowski J.Q., Gibbs J.R., Brunetti M., Gronka S., Wuu J.et al. .. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron. 2010; 68:857&#x2013;864.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3032425</ArticleId><ArticleId IdType="pubmed">21145000</ArticleId></ArticleIdList></Reference><Reference><Citation>Serio A., Patani R.. Concise Review: The cellular conspiracy of amyotrophic lateral sclerosis. Stem Cells. 2018; 36:293&#x2013;303.</Citation><ArticleIdList><ArticleId IdType="pubmed">29235200</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyzack G., Lakatos A., Patani R.. Human stem cell-derived Astrocytes: Specification and relevance for neurological disorders. Curr. Stem Cell. Rep. 2016; 2:236&#x2013;247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4972864</ArticleId><ArticleId IdType="pubmed">27547709</ArticleId></ArticleIdList></Reference><Reference><Citation>Sofroniew M.V., Vinters H.V.. Astrocytes: biology and pathology. Acta Neuropathol. 2010; 119:7&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2799634</ArticleId><ArticleId IdType="pubmed">20012068</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyzack G.E., Hall C.E., Sibley C.R., Cymes T., Forostyak S., Carlino G., Meyer I.F., Schiavo G., Zhang S.-C., Gibbons G.M.et al. .. A neuroprotective astrocyte state is induced by neuronal signal EphB1 but fails in ALS models. Nat. Commun. 2017; 8:1164.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5660125</ArticleId><ArticleId IdType="pubmed">29079839</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao C., Devlin A.-C., Chouhan A.K., Selvaraj B.T., Stavrou M., Burr K., Brivio V., He X., Mehta A.R., Story D.et al. .. Mutant C9orf72 human iPSC-derived astrocytes cause non-cell autonomous motor neuron pathophysiology. Glia. 2019; 68:1046&#x2013;1106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7078830</ArticleId><ArticleId IdType="pubmed">31841614</ArticleId></ArticleIdList></Reference><Reference><Citation>Serio A., Bilican B., Barmada S.J., Ando D.M., Zhao C., Siller R., Burr K., Haghi G., Story D., Nishimura A.L.et al. .. Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy. Proc. Natl. Acad. Sci. USA. 2013; 110:4697&#x2013;4702.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3607024</ArticleId><ArticleId IdType="pubmed">23401527</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall C.E., Yao Z., Choi M., Tyzack G.E., Serio A., Luisier R., Harley J., Preza E., Arber C., Crisp S.J.et al. .. Progressive Motor Neuron Pathology and the Role of Astrocytes in a Human Stem Cell Model of VCP-Related ALS. Cell Rep. 2017; 19:1739&#x2013;1749.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5464993</ArticleId><ArticleId IdType="pubmed">28564594</ArticleId></ArticleIdList></Reference><Reference><Citation>Di&#xa0;Giorgio F.P., Carrasco M.A., Siao M.C., Maniatis T., Eggan K.. Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat. Neurosci. 2007; 10:608&#x2013;614.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3139463</ArticleId><ArticleId IdType="pubmed">17435754</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer K., Ferraiuolo L., Miranda C.J., Likhite S., McElroy S., Renusch S., Ditsworth D., Lagier-Tourenne C., Smith R.A., Ravits J.et al. .. Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS. Proc. Natl. Acad. Sci. USA. 2014; 111:829&#x2013;832.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3896192</ArticleId><ArticleId IdType="pubmed">24379375</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K., Chun S.J., Boillee S., Fujimori-Tonou N., Yamashita H., Gutmann D.H., Takahashi R., Misawa H., Cleveland D.W.. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 2008; 11:251&#x2013;253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3137510</ArticleId><ArticleId IdType="pubmed">18246065</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai M., Re D.B., Nagata T., Chalazonitis A., Jessell T.M., Wichterle H., Przedborski S.. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat. Neurosci. 2007; 10:615&#x2013;622.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3799799</ArticleId><ArticleId IdType="pubmed">17435755</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidet-Phillips A.M., Hester M.E., Miranda C.J., Meyer K., Braun L., Frakes A., Song S., Likhite S., Murtha M.J., Foust K.D.et al. .. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat. Biotechnol. 2011; 29:824&#x2013;828.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3170425</ArticleId><ArticleId IdType="pubmed">21832997</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchetto M.C.N., Muotri A.R., Mu Y., Smith A.M., Cezar G.G., Gage F.H. Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells. Cell Stem Cell. 2008; 3:649&#x2013;657.</Citation><ArticleIdList><ArticleId IdType="pubmed">19041781</ArticleId></ArticleIdList></Reference><Reference><Citation>Brohawn D.G., O&#x2019;Brien L.C., Bennett J.P. Jr. RNAseq Analyses Identify Tumor Necrosis Factor-Mediated Inflammation as a Major Abnormality in ALS Spinal Cord. PLoS One. 2016; 11:e0160520.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4972368</ArticleId><ArticleId IdType="pubmed">27487029</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J., Green C., Altschuler G., Wei W., Bury J.J., Heath P.R., Wyles M., Gelsthorpe C., Highley J.R., Lorente-Pons A.et al. .. A data-driven approach links microglia to pathology and prognosis in amyotrophic lateral sclerosis. Acta Neuropathol. Commun. 2017; 5:23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5353945</ArticleId><ArticleId IdType="pubmed">28302159</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam O.H., Rozhkov N.V., Shaw R., Kim D., Hubbard I., Fennessey S., Propp N.NYGC ALS Consortium NYGC ALS Consortium Fagegaltier D., Harris B.T.et al. .. Postmortem cortex samples identify distinct molecular subtypes of ALS: Retrotransposon activation, oxidative stress, and activated glia. Cell Rep. 2019; 29:1164&#x2013;1177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6866666</ArticleId><ArticleId IdType="pubmed">31665631</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Erchia A.M., Gallo A., Manzari C., Raho S., Horner D.S., Chiara M., Valletti A., Aiello I., Mastropasqua F., Ciaccia L.et al. .. Massive transcriptome sequencing of human spinal cord tissues provides new insights into motor neuron degeneration in ALS. Sci. Rep. 2017; 7:10046.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5577269</ArticleId><ArticleId IdType="pubmed">28855684</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiffer D., Cordera S., Cavalla P., Migheli A.. Reactive astrogliosis of the spinal cord in amyotrophic lateral sclerosis. J. Neurol. Sci. 1996; 139:27&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">8899654</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy D., Kato T., Kushner P.D.. Reactive astrocytes are widespread in the cortical gray matter of amyotrophic lateral sclerosis. J. Neurosci. Res. 1994; 38:336&#x2013;347.</Citation><ArticleIdList><ArticleId IdType="pubmed">7523689</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow S.A., Guttenplan K.A., Clarke L.E., Bennett F.C., Bohlen C.J., Schirmer L., Bennett M.L., M&#xfc;nch A.E., Chung W.-S., Peterson T.C.et al. .. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017; 541:481&#x2013;487.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5404890</ArticleId><ArticleId IdType="pubmed">28099414</ArticleId></ArticleIdList></Reference><Reference><Citation>Cahoy J.D., Emery B., Kaushal A., Foo L.C., Zamanian J.L., Christopherson K.S., Xing Y., Lubischer J.L., Krieg P.A., Krupenko S.A.et al. .. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J. Neurosci. 2008; 28:264&#x2013;278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6671143</ArticleId><ArticleId IdType="pubmed">18171944</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamanian J.L., Xu L., Foo L.C., Nouri N., Zhou L., Giffard R.G., Barres B.A.. Genomic analysis of reactive astrogliosis. J. Neurosci. 2012; 32:6391&#x2013;6410.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3480225</ArticleId><ArticleId IdType="pubmed">22553043</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbar L., Jain T., Zimmer M., Kruglikov I., Sadick J.S., Wang M., Kalpana K., Rose I.V.L., Burstein S.R., Rusielewicz T.et al. .. CD49f is a novel marker of functional and reactive human iPSC-Derived astrocytes. Neuron. 2020; 107:436&#x2013;453.</Citation><ArticleIdList><ArticleId IdType="pubmed">32485136</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Chen K., Sloan S.A., Bennett M.L., Scholze A.R., O&#x2019;Keeffe S., Phatnani H.P., Guarnieri P., Caneda C., Ruderisch N.et al. .. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J. Neurosci. 2014; 34:11929&#x2013;11947.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4152602</ArticleId><ArticleId IdType="pubmed">25186741</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas M.R., Pehar M., D&#xed;az-Amarilla P.J., Beckman J.S., Barbeito L.. Transcriptional profile of primary astrocytes expressing ALS-linked mutant SOD1. J. Neurosci. Res. 2008; 86:3515&#x2013;3525.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4048747</ArticleId><ArticleId IdType="pubmed">18683239</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauger O., Lemoine F., Scheiffele P.. Targeted intron retention and excision for rapid gene regulation in response to neuronal activity. Neuron. 2016; 92:1266&#x2013;1278.</Citation><ArticleIdList><ArticleId IdType="pubmed">28009274</ArticleId></ArticleIdList></Reference><Reference><Citation>Naro C., Jolly A., Di&#xa0;Persio S., Bielli P., Setterblad N., Alberdi A.J., Vicini E., Geremia R., De&#xa0;la&#xa0;Grange P., Sette C.. An orchestrated intron retention program in meiosis controls timely usage of transcripts during germ cell differentiation. Dev. Cell. 2017; 41:82&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5392497</ArticleId><ArticleId IdType="pubmed">28366282</ArticleId></ArticleIdList></Reference><Reference><Citation>Yap K., Lim Z.Q., Khandelia P., Friedman B., Makeyev E.V.. Coordinated regulation of neuronal mRNA steady-state levels through developmentally controlled intron retention. Genes Dev. 2012; 26:1209&#x2013;1223.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3371409</ArticleId><ArticleId IdType="pubmed">22661231</ArticleId></ArticleIdList></Reference><Reference><Citation>Green I.D., Pinello N., Song R., Lee Q., Halstead J.M., Kwok C.-T., Wong A.C.H., Nair S.S., Clark S.J., Roediger B.et al. .. Macrophage development and activation involve coordinated intron retention in key inflammatory regulators. Nucleic Acids Res. 2020; 48:6513&#x2013;6529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7337907</ArticleId><ArticleId IdType="pubmed">32449925</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni T., Yang W., Han M., Zhang Y., Shen T., Nie H., Zhou Z., Dai Y., Yang Y., Liu P.et al. .. Global intron retention mediated gene regulation during CD4+ T cell activation. Nucleic Acids Res. 2016; 44:6817&#x2013;6829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5001615</ArticleId><ArticleId IdType="pubmed">27369383</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong J.J.-L., Au A.Y.M., Ritchie W., Rasko J.E.J.. Intron retention in mRNA: No longer nonsense: Known and putative roles of intron retention in normal and disease biology. BioEssays. 2016; 38:41&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">26612485</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong J.J.-L., Ritchie W., Ebner O.A., Selbach M., Wong J.W.H., Huang Y., Gao D., Pinello N., Gonzalez M., Baidya K.et al. .. Orchestrated intron retention regulates normal granulocyte differentiation. Cell. 2013; 154:583&#x2013;595.</Citation><ArticleIdList><ArticleId IdType="pubmed">23911323</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaillon O., Bouhouche K., Gout J.-F., Aury J.-M., Noel B., Saudemont B., Nowacki M., Serrano V., Porcel B.M., S&#xe9;gurens B.et al. .. Translational control of intron splicing in eukaryotes. Nature. 2008; 451:359&#x2013;362.</Citation><ArticleIdList><ArticleId IdType="pubmed">18202663</ArticleId></ArticleIdList></Reference><Reference><Citation>Boutz P.L., Bhutkar A., Sharp P.A.. Detained introns are a novel, widespread class of post-transcriptionally spliced introns. Genes Dev. 2015; 29:63&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4281565</ArticleId><ArticleId IdType="pubmed">25561496</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemieux C., Marguerat S., Lafontaine J., Barbezier N., B&#xe4;hler J., Bachand F.. A Pre-mRNA degradation pathway that selectively targets intron-containing genes requires the nuclear poly(A)-binding protein. Mol. Cell. 2011; 44:108&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pubmed">21981922</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahar&#xa0;Halpern K., Caspi I., Lemze D., Levy M., Landen S., Elinav E., Ulitsky I., Itzkovitz S.. Nuclear Retention of mRNA in Mammalian Tissues. Cell Rep. 2015; 13:2653&#x2013;2662.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4700052</ArticleId><ArticleId IdType="pubmed">26711333</ArticleId></ArticleIdList></Reference><Reference><Citation>Luisier R., Tyzack G.E., Hall C.E., Mitchell J.S., Devine H., Taha D.M., Malik B., Meyer I., Greensmith L., Newcombe J.et al. .. Intron retention and nuclear loss of SFPQ are molecular hallmarks of ALS. Nat. Commun. 2018; 9:2010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5964114</ArticleId><ArticleId IdType="pubmed">29789581</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyzack G.E., Neeves J., Klein P., Crerar H., Ziff O., Taha D.M., Luisier R., Luscombe N.M., Patani R.. An aberrant cytoplasmic intron retention program is a blueprint RBP mislocalization in VCP-related ALS. 2021; BioRxiv doi:21 July 2020, preprint: not peer reviewed10.1101/2020.07.20.211557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.07.20.211557</ArticleId><ArticleId IdType="pubmed">33693641</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh Y.-C., Guo C., Yalamanchili H.K., Abreha M., Al-Ouran R., Li Y., Dammer E.B., Lah J.J., Levey A.I., Bennett D.A.et al. .. Tau-Mediated disruption of the spliceosome triggers cryptic RNA splicing and neurodegeneration in Alzheimer's disease. Cell Rep. 2019; 29:301&#x2013;316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6919331</ArticleId><ArticleId IdType="pubmed">31597093</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphrey J., Birsa N., Milioto C., McLaughlin M., Ule A.M., Robaldo D., Eberle A.B., Kr&#xe4;uchi R., Bentham M., Brown A.-L.et al. .. FUS ALS-causative mutations impair FUS autoregulation and splicing factor networks through intron retention. Nucleic Acids Res. 2020; 48:6889&#x2013;6905.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7337901</ArticleId><ArticleId IdType="pubmed">32479602</ArticleId></ArticleIdList></Reference><Reference><Citation>Adusumalli S., Ngian Z.-K., Lin W.-Q., Benoukraf T., Ong C.-T.. Increased intron retention is a post-transcriptional signature associated with progressive aging and Alzheimer&#x2019;s disease. Aging Cell. 2019; 18:e12928.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6516162</ArticleId><ArticleId IdType="pubmed">30868713</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Conlon E., Manley J., Rio D.. Widespread intron retention impairs protein homeostasis in C9orf72 ALS brains. Genome Res. 2020; 30:1705&#x2013;1715.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7706729</ArticleId><ArticleId IdType="pubmed">33055097</ArticleId></ArticleIdList></Reference><Reference><Citation>Ullrich S., Guig&#xf3; R.. Dynamic changes in intron retention are tightly associated with regulation of splicing factors and proliferative activity during B-cell development. Nucleic Acids Res. 2020; 48:1327&#x2013;1340.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7026658</ArticleId><ArticleId IdType="pubmed">31879760</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelley K.W., Ben&#xa0;Haim L., Schirmer L., Tyzack G.E., Tolman M., Miller J.G., Tsai H.-H., Chang S.M., Molofsky A.V., Yang Y.et al. .. Kir4.1-dependent astrocyte-fast motor neuron interactions are required for peak strength. Neuron. 2018; 98:306&#x2013;319.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5919779</ArticleId><ArticleId IdType="pubmed">29606582</ArticleId></ArticleIdList></Reference><Reference><Citation>Thelin E.P., Hall C.E., Tyzack G.E., Frostell A., Giorgi-Coll S., Alam A., Carpenter K.L.H., Mitchell J., Tajsic T., Hutchinson P.J.et al. .. Delineating astrocytic cytokine responses in a human stem cell model of neural trauma. J. Neurotrauma. 2020; 37:93&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6921298</ArticleId><ArticleId IdType="pubmed">31452443</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke B.E., Taha D.M., Ziff O.J., Alam A., Thelin E.P., Garc&#xed;a N.M., Helmy A., Patani R.. Human stem cell-derived astrocytes exhibit region-specific heterogeneity in their secretory profiles. Brain. 2020; 143:e85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7586081</ArticleId><ArticleId IdType="pubmed">32895697</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziff O.J., Patani R.. Harnessing cellular aging in human stem cell models of amyotrophic lateral sclerosis. Aging Cell. 2019; 18:e12862.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6351881</ArticleId><ArticleId IdType="pubmed">30565851</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A., Davis C.A., Schlesinger F., Drenkow J., Zaleski C., Jha S., Batut P., Chaisson M., Gingeras T.R.. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013; 29:15&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Anders S., Pyl P.T., Huber W.. HTSeq&#x2014;a Python framework to work with high-throughput sequencing data. Bioinformatics. 2014; 31:166&#x2013;169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4287950</ArticleId><ArticleId IdType="pubmed">25260700</ArticleId></ArticleIdList></Reference><Reference><Citation>Ewels P., Peltzer A., Fillinger S., Patel H., Alneberg J., Wilm A., Garcia M.U., Tommaso P.D., Nahnsen S.. The nf-core framework for community-curated bioinformatics pipelines. Nature Biotech. 2020; 38:276&#x2013;278.</Citation><ArticleIdList><ArticleId IdType="pubmed">32055031</ArticleId></ArticleIdList></Reference><Reference><Citation>Love M.I., Huber W., Anders S.. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014; 15:550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapial J., Ha K.C.H., Sterne-Weiler T., Gohr A., Braunschweig U., Hermoso-Pulido A., Quesnel-Valli&#xe8;res M., Permanyer J., Sodaei R., Marquez Y.et al. .. An atlas of alternative splicing profiles and functional associations reveals new regulatory programs and genes that simultaneously express multiple major isoforms. Genome Res. 2017; 27:1759&#x2013;1768.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5630039</ArticleId><ArticleId IdType="pubmed">28855263</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein L.D., Cao Y., Pau G., Lawrence M., Wu T.D., Seshagiri S., Gentleman R.. Prediction and quantification of splice events from RNA-Seq Data. PLoS One. 2016; 11:e0156132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4878813</ArticleId><ArticleId IdType="pubmed">27218464</ArticleId></ArticleIdList></Reference><Reference><Citation>Middleton R., Gao D., Thomas A., Singh B., Au A., Wong J.J.-L., Bomane A., Cosson B., Eyras E., Rasko J.E.J.et al. .. IRFinder: assessing the impact of intron retention on mammalian gene expression. Genome Biol. 2017; 18:51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5353968</ArticleId><ArticleId IdType="pubmed">28298237</ArticleId></ArticleIdList></Reference><Reference><Citation>Raudvere U., Kolberg L., Kuzmin I., Arak T., Adler P., Peterson H., Vilo J.. g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update). Nucleic Acids Res. 2019; 47:W191&#x2013;W198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6602461</ArticleId><ArticleId IdType="pubmed">31066453</ArticleId></ArticleIdList></Reference><Reference><Citation>Korotkevich G., Sukhov V., Sergushichev A.. Fast Gene Set Enrichment Analysis. 2019; Cold Spring Harbor Laboratory; doi:10.1101/060012.</Citation></Reference><Reference><Citation>Gene Ontology Consortium Nuclear-transcribed mRNA catabolic process, nonsense-mediated decay. 2021; GO:0000184.</Citation></Reference><Reference><Citation>Attig J., Agostini F., Gooding C., Chakrabarti A.M., Singh A., Haberman N., Zagalak J.A., Emmett W., Smith C.W.J., Luscombe N.M.et al. .. Heteromeric RNP assembly at LINEs controls lineage-specific RNA processing. Cell. 2018; 174:1067&#x2013;1081.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6108849</ArticleId><ArticleId IdType="pubmed">30078707</ArticleId></ArticleIdList></Reference><Reference><Citation>Sloan C.A., Chan E.T., Davidson J.M., Malladi V.S., Strattan J.S., Hitz B.C., Gabdank I., Narayanan A.K., Ho M., Lee B.T.et al. .. ENCODE data at the ENCODE portal. Nucleic Acids Res. 2016; 44:D726&#x2013;D732.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4702836</ArticleId><ArticleId IdType="pubmed">26527727</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeo G., Burge C.B.. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J. Comput. Biol. 2004; 11:377&#x2013;394.</Citation><ArticleIdList><ArticleId IdType="pubmed">15285897</ArticleId></ArticleIdList></Reference><Reference><Citation>Bray N.L., Pimentel H., Melsted P., Pachter L.. Near-optimal probabilistic RNA-seq quantification. Nat. Biotechnol. 2016; 34:525&#x2013;527.</Citation><ArticleIdList><ArticleId IdType="pubmed">27043002</ArticleId></ArticleIdList></Reference><Reference><Citation>Birger A., Ben-Dor I., Ottolenghi M., Turetsky T., Gil Y., Sweetat S., Perez L., Belzer V., Casden N., Steiner D.et al. .. Human iPSC-derived astrocytes from ALS patients with mutated C9ORF72 show increased oxidative stress and neurotoxicity. EBioMedicine. 2019; 50:274&#x2013;289.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6921360</ArticleId><ArticleId IdType="pubmed">31787569</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S., Sun Y., Ling S.-C., Ferraiuolo L., McAlonis-Downes M., Zou Y., Drenner K., Wang Y., Ditsworth D., Tokunaga S.et al. .. Translational profiling identifies a cascade of damage initiated in motor neurons and spreading to glia in mutant SOD1-mediated ALS. Proc. Natl. Acad. Sci. USA. 2015; 112:E6993&#x2013;E7002.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4687558</ArticleId><ArticleId IdType="pubmed">26621731</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng A.Y.T., Agrawal I., Ho W.Y., Yen Y.-C., Pinter A.J., Liu J., Phua Q.X.C., Koh K.B., Chang J.-C., Sanford E.et al. .. Loss of TDP-43 in astrocytes leads to motor deficits by triggering A1-like reactive phenotype and triglial dysfunction. Proc. Natl. Acad. Sci. USA. 2020; 117:29101&#x2013;29112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7682406</ArticleId><ArticleId IdType="pubmed">33127758</ArticleId></ArticleIdList></Reference><Reference><Citation>Broseus L., Ritchie W.. Challenges in detecting and quantifying intron retention from next generation sequencing data. Comput. Struct. Biotechnol. J. 2020; 18:501&#x2013;508.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7078297</ArticleId><ArticleId IdType="pubmed">32206209</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Smits A.H., van&#xa0;Tilburg G.B., Ovaa H., Huber W., Vermeulen M.. Proteome-wide identification of ubiquitin interactions using UbIA-MS. Nat. Protoc. 2018; 13:530&#x2013;550.</Citation><ArticleIdList><ArticleId IdType="pubmed">29446774</ArticleId></ArticleIdList></Reference><Reference><Citation>Smethurst P., Risse E., Tyzack G.E., Mitchell J.S., Taha D.M., Chen Y.-R., Newcombe J., Collinge J., Sidle K., Patani R.. Distinct responses of neurons and astrocytes to TDP-43 proteinopathy in amyotrophic lateral sclerosis. Brain. 2020; 143:430&#x2013;440.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7009461</ArticleId><ArticleId IdType="pubmed">32040555</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine J., Kwon E., Paez P., Yan W., Czerwieniec G., Loo J.A., Sofroniew M.V., Wanner I.-B.. Traumatically injured astrocytes release a proteomic signature modulated by STAT3-dependent cell survival. Glia. 2016; 64:668&#x2013;694.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4805454</ArticleId><ArticleId IdType="pubmed">26683444</ArticleId></ArticleIdList></Reference><Reference><Citation>Galante P.A.F., Sakabe N.J., Kirschbaum-Slager N., de&#xa0;Souza S.J. Detection and evaluation of intron retention events in the human transcriptome. RNA. 2004; 10:757&#x2013;765.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1370565</ArticleId><ArticleId IdType="pubmed">15100430</ArticleId></ArticleIdList></Reference><Reference><Citation>Braunschweig U., Barbosa-Morais N.L., Pan Q., Nachman E.N., Alipanahi B., Gonatopoulos-Pournatzis T., Frey B., Irimia M., Blencowe B.J.. Widespread intron retention in mammals functionally tunes transcriptomes. Genome Res. 2014; 24:1774&#x2013;1786.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4216919</ArticleId><ArticleId IdType="pubmed">25258385</ArticleId></ArticleIdList></Reference><Reference><Citation>Van&#xa0;Nostrand E.L., Freese P., Pratt G.A., Wang X., Wei X., Xiao R., Blue S.M., Chen J.-Y., Cody N.A.L., Dominguez D.et al. .. A large-scale binding and functional map of human RNA-binding proteins. Nature. 2020; 583:711&#x2013;719.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7410833</ArticleId><ArticleId IdType="pubmed">32728246</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge Y., Porse B.T.. The functional consequences of intron retention: alternative splicing coupled to NMD as a regulator of gene expression. Bioessays. 2014; 36:236&#x2013;243.</Citation><ArticleIdList><ArticleId IdType="pubmed">24352796</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob A.G., Smith C.W.J. Intron retention as a component of regulated gene expression programs. Hum. Genet. 2017; 136:1043&#x2013;1057.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5602073</ArticleId><ArticleId IdType="pubmed">28391524</ArticleId></ArticleIdList></Reference><Reference><Citation>Neo S.H., Tang B.L.. Collagen 1 signaling at the central nervous system injury site and astrogliosis. Neural Regener. Res. 2017; 12:1600&#x2013;1601.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5696833</ArticleId><ArticleId IdType="pubmed">29171417</ArticleId></ArticleIdList></Reference><Reference><Citation>Teh D.B.L., Prasad A., Jiang W., Ariffin M.Z., Khanna S., Belorkar A., Wong L., Liu X., All A.H. Transcriptome analysis reveals neuroprotective aspects of human reactive astrocytes induced by interleukin 1&#x3b2;. Sci. Rep. 2017; 7:13988.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5656635</ArticleId><ArticleId IdType="pubmed">29070875</ArticleId></ArticleIdList></Reference><Reference><Citation>Hara M., Kobayakawa K., Ohkawa Y., Kumamaru H., Yokota K., Saito T., Kijima K., Yoshizaki S., Harimaya K., Nakashima Y.et al. .. Interaction of reactive astrocytes with type I collagen induces astrocytic scar formation through the integrin-N-cadherin pathway after spinal cord injury. Nat. Med. 2017; 23:818&#x2013;828.</Citation><ArticleIdList><ArticleId IdType="pubmed">28628111</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajmone-Cat M.A., Onori A., Toselli C., Stronati E., Morlando M., Bozzoni I., Monni E., Kokaia Z., Lupo G., Minghetti L.et al. .. Increased FUS levels in astrocytes leads to astrocyte and microglia activation and neuronal death. Sci. Rep. 2019; 9:4572.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6418113</ArticleId><ArticleId IdType="pubmed">30872738</ArticleId></ArticleIdList></Reference><Reference><Citation>Price A.J., Hwang T., Tao R., Burke E.E., Rajpurohit A., Shin J.H., Hyde T.M., Kleinman J.E., Jaffe A.E., Weinberger D.R.. Characterizing the nuclear and cytoplasmic transcriptomes in developing and mature human cortex uncovers new insight into psychiatric disease gene regulation. Genome Res. 2020; 30:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6961577</ArticleId><ArticleId IdType="pubmed">31852722</ArticleId></ArticleIdList></Reference><Reference><Citation>Guttenplan K.A., Weigel M.K., Adler D.I., Couthouis J., Liddelow S.A., Gitler A.D., Barres B.A.. Knockout of reactive astrocyte activating factors slows disease progression in an ALS mouse model. Nat. Commun. 2020; 11:3753.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385161</ArticleId><ArticleId IdType="pubmed">32719333</ArticleId></ArticleIdList></Reference><Reference><Citation>Sznajder &#x141;.J., Thomas J.D., Carrell E.M., Reid T., McFarland K.N., Cleary J.D., Oliveira R., Nutter C.A., Bhatt K., Sobczak K.et al. .. Intron retention induced by microsatellite expansions as a disease biomarker. Proc. Natl. Acad. Sci. USA. 2018; 115:4234&#x2013;4239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5910826</ArticleId><ArticleId IdType="pubmed">29610297</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai G., Lipton S.A.. Aberrant RNA splicing minireview in sporadic amyotrophic lateral sclerosis. Neuro. 1998; 20:363&#x2013;366.</Citation><ArticleIdList><ArticleId IdType="pubmed">9539113</ArticleId></ArticleIdList></Reference><Reference><Citation>Flomen R., Makoff A.. Increased RNA editing in EAAT2 pre-mRNA from amyotrophic lateral sclerosis patients: involvement of a cryptic polyadenylation site. Neurosci. Lett. 2011; 497:139&#x2013;143.</Citation><ArticleIdList><ArticleId IdType="pubmed">21569822</ArticleId></ArticleIdList></Reference><Reference><Citation>Hock E.-M., Maniecka Z., Hruska-Plochan M., Reber S., Laferri&#xe8;re F., Sahadevan&#xa0;M&#xa0;K S., Ederle H., Gittings L., Pelkmans L., Dupuis L.et al. .. Hypertonic stress causes cytoplasmic translocation of neuronal, but not astrocytic, FUS due to impaired transportin function. Cell Rep. 2018; 24:987&#x2013;1000.</Citation><ArticleIdList><ArticleId IdType="pubmed">30044993</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Q., Walker D., Bernardo A., Brodbeck J., Balestra M.E., Huang Y.. Intron-3 retention/splicing controls neuronal expression of apolipoprotein E in the CNS. J. Neurosci. 2008; 28:1452&#x2013;1459.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6671590</ArticleId><ArticleId IdType="pubmed">18256266</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu C.-H., Davidson S., Harapas C.R., Hilton J.B., Mlodzianoski M.J., Laohamonthonkul P., Louis C., Low R.R.J., Moecking J., De&#xa0;Nardo D.et al. .. TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS. Cell. 2020; 183:636&#x2013;649.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7599077</ArticleId><ArticleId IdType="pubmed">33031745</ArticleId></ArticleIdList></Reference><Reference><Citation>Velebit J., Horvat A., Smoli&#x10d; T., Prpar&#xa0;Mihevc S., Rogelj B., Zorec R., Vardjan N.. Astrocytes with TDP-43 inclusions exhibit reduced noradrenergic cAMP and Ca2+ signaling and dysregulated cell metabolism. Sci. Rep. 2020; 10:6003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7138839</ArticleId><ArticleId IdType="pubmed">32265469</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuiji H., Iguchi Y., Furuya A., Kataoka A., Hatsuta H., Atsuta N., Tanaka F., Hashizume Y., Akatsu H., Murayama S.et al. .. Spliceosome integrity is defective in the motor neuron diseases ALS and SMA. EMBO Mol. Med. 2013; 5:221&#x2013;234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3569639</ArticleId><ArticleId IdType="pubmed">23255347</ArticleId></ArticleIdList></Reference><Reference><Citation>La&#xa0;Cognata V., Gentile G., Aronica E., Cavallaro S.. Splicing players are differently expressed in sporadic amyotrophic lateral sclerosis molecular clusters and brain regions. Cells. 2020; 9:159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7017305</ArticleId><ArticleId IdType="pubmed">31936368</ArticleId></ArticleIdList></Reference><Reference><Citation>Fratta P., Isaacs A.M.. The snowball effect of RNA binding protein dysfunction in amyotrophic lateral sclerosis. Brain. 2018; 141:1236&#x2013;1238.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5917769</ArticleId><ArticleId IdType="pubmed">29701791</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Patani R.. Novel therapeutic targets for amyotrophic lateral sclerosis: ribonucleoproteins and cellular autonomy. Expert Opin. Ther. Targets. 2020; 24:971&#x2013;984.</Citation><ArticleIdList><ArticleId IdType="pubmed">32746659</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckley P.T., Khaladkar M., Kim J., Eberwine J.. Cytoplasmic intron retention, function, splicing, and the sentinel RNA hypothesis. Wiley Interdiscip. Rev. RNA. 2014; 5:223&#x2013;230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4449146</ArticleId><ArticleId IdType="pubmed">24190870</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckley P.T., Lee M.T., Sul J.-Y., Miyashiro K.Y., Bell T.J., Fisher S.A., Kim J., Eberwine J.. Cytoplasmic intron sequence-retaining transcripts can be dendritically targeted via ID element retrotransposons. Neuron. 2011; 69:877&#x2013;884.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3065018</ArticleId><ArticleId IdType="pubmed">21382548</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabrez S.S., Sharma R.D., Jain V., Siddiqui A.A., Mukhopadhyay A.. Differential alternative splicing coupled to nonsense-mediated decay of mRNA ensures dietary restriction-induced longevity. Nat. Commun. 2017; 8:306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5563511</ArticleId><ArticleId IdType="pubmed">28824175</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis B.P., Green R.E., Brenner S.E.. Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proc. Natl. Acad. Sci. USA. 2003; 100:189&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC140922</ArticleId><ArticleId IdType="pubmed">12502788</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Y.-F., Imam J.S., Wilkinson M.F.. The nonsense-mediated decay RNA surveillance pathway. Annu. Rev. Biochem. 2007; 76:51&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">17352659</ArticleId></ArticleIdList></Reference><Reference><Citation>Hug N., Longman D., C&#xe1;ceres J.F.. Mechanism and regulation of the nonsense-mediated decay pathway. Nucleic Acids Res. 2016; 44:1483&#x2013;1495.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4770240</ArticleId><ArticleId IdType="pubmed">26773057</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetz A.E., Wilkinson M.. Stress and the nonsense-mediated RNA decay pathway. Cell. Mol. Life Sci. 2017; 74:3509&#x2013;3531.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5683946</ArticleId><ArticleId IdType="pubmed">28503708</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson J.L., Stoica L., Liu Y., Zhu P.J., Bhattacharya A., Buffington S.A., Huq R., Eissa N.T., Larsson O., Porse B.T.et al. .. Inhibition of Upf2-Dependent nonsense-mediated decay leads to behavioral and neurophysiological abnormalities by activating the immune response. Neuron. 2019; 104:665&#x2013;679.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7312756</ArticleId><ArticleId IdType="pubmed">31585809</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J., Plank T.-D., Su F., Shi X., Liu C., Ji Y., Li S., Huynh A., Shi C., Zhu B.et al. .. The nonsense-mediated RNA decay pathway is disrupted in inflammatory myofibroblastic tumors. J. Clin. Invest. 2016; 126:3058&#x2013;3062.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4966300</ArticleId><ArticleId IdType="pubmed">27348585</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho W.Y., Agrawal I., Tyan S.-H., Sanford E., Chang W.-T., Lim K., Ong J., Tan B.S.Y., Moe A.A.K., Yu R.et al. .. Dysfunction in nonsense-mediated decay, protein homeostasis, mitochondrial function, and brain connectivity in ALS-FUS mice with cognitive deficits. Acta Neuropathol. Commun. 2021; 9:9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7789430</ArticleId><ArticleId IdType="pubmed">33407930</ArticleId></ArticleIdList></Reference><Reference><Citation>Lareau L.F., Inada M., Green R.E., Wengrod J.C., Brenner S.E.. Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements. Nature. 2007; 446:926&#x2013;929.</Citation><ArticleIdList><ArticleId IdType="pubmed">17361132</ArticleId></ArticleIdList></Reference><Reference><Citation>Song S., Miranda C.J., Braun L., Meyer K., Frakes A.E., Ferraiuolo L., Likhite S., Bevan A.K., Foust K.D., McConnell M.J.et al. .. Major histocompatibility complex class I molecules protect motor neurons from astrocyte-induced toxicity in amyotrophic lateral sclerosis. Nat. Med. 2016; 22:397&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4823173</ArticleId><ArticleId IdType="pubmed">26928464</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>